Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease
- 7 January 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (5), 1173-1178
- https://doi.org/10.1016/j.kint.2020.12.024
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by DialysisAmerican Journal of Kidney Diseases, 2016
- Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidismKidney International, 2015
- When, How, and Why a Bone Biopsy Should Be Performed in Patients With Chronic Kidney DiseaseSeminars in Nephrology, 2014
- Nonoxidized, Biologically Active Parathyroid Hormone Determines Mortality in Hemodialysis PatientsJournal of Clinical Endocrinology & Metabolism, 2013
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress – Do We Need a Fourth Generation Parathyroid Hormone Assay?PLOS ONE, 2012
- Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular diseaseKidney International, 2008
- A Structural and Mechanistic Study of the Oxidation of Methionine Residues in hPTH(1−34) via Experiments and SimulationsBiochemistry, 2004
- Peripheral Metabolism of Intact Parathyroid HormoneJCI Insight, 1981
- Selective Uptake of the Synthetic Amino Terminal Fragment of Bovine Parathyroid Hormone by Isolated Perfused BoneJCI Insight, 1978